Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Leonard

Showing results (11-20 of 299) with videos related to

Pageof 30
Sort By:
Hematology. American Society of Hematology. Education Program|January 18, 2011
Novel agents for follicular lymphomaJohn P Leonard, Peter Martin
Leukemia & Lymphoma|May 20, 2009
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphomaJia Ruan, John P Leonard
Leukemia & Lymphoma|July 7, 2007
IL-4 as therapy for non-Hodgkin's lymphoma: possibilities but major challengesPeter Martin, John P Leonard
Expert Opinion on Therapeutic Targets|July 7, 2007
Novel therapeutic targets in mantle cell lymphomaPeter Martin, John P Leonard
Haematologica|May 18, 2023
Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?Erin Mulvey, John P Leonard
Clinical Lymphoma & Myeloma|November 15, 2006
Should all patients with indolent lymphoma be treated with rituximab maintenance therapy? An overview of the dataBiree Andemariam, John P Leonard
Cancer Treatment and Research|May 18, 2006
Mantle cell lymphoma: current concept in biology and treatmentJia Ruan, John P Leonard
The New England Journal of Medicine|March 3, 2016
Lenalidomide plus Rituximab for Mantle-Cell LymphomaJia Ruan, John P Leonard
Leukemia & Lymphoma|June 25, 2011
Advancing through maintenance in mantle cell lymphomaPeter Martin, John P Leonard
Hematology. American Society of Hematology. Education Program|December 10, 2013
Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOPLeandro Cerchietti, John P Leonard
Pageof 30

Showing results (11-20 of 299) with videos related to

Sort By:
Pageof 30
Hematology. American Society of Hematology. Education Program|January 18, 2011
Novel agents for follicular lymphomaJohn P Leonard, Peter Martin
Leukemia & Lymphoma|May 20, 2009
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphomaJia Ruan, John P Leonard
Leukemia & Lymphoma|July 7, 2007
IL-4 as therapy for non-Hodgkin's lymphoma: possibilities but major challengesPeter Martin, John P Leonard
Expert Opinion on Therapeutic Targets|July 7, 2007
Novel therapeutic targets in mantle cell lymphomaPeter Martin, John P Leonard
Haematologica|May 18, 2023
Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?Erin Mulvey, John P Leonard
Clinical Lymphoma & Myeloma|November 15, 2006
Should all patients with indolent lymphoma be treated with rituximab maintenance therapy? An overview of the dataBiree Andemariam, John P Leonard
Cancer Treatment and Research|May 18, 2006
Mantle cell lymphoma: current concept in biology and treatmentJia Ruan, John P Leonard
The New England Journal of Medicine|March 3, 2016
Lenalidomide plus Rituximab for Mantle-Cell LymphomaJia Ruan, John P Leonard
Leukemia & Lymphoma|June 25, 2011
Advancing through maintenance in mantle cell lymphomaPeter Martin, John P Leonard
Hematology. American Society of Hematology. Education Program|December 10, 2013
Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOPLeandro Cerchietti, John P Leonard
Pageof 30